Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Maartense

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
British Journal of Cancer|June 13, 2001
Patients' preferences for adjuvant chemotherapy in early-stage breast cancer: is treatment worthwhile?S J Jansen, J Kievit, M A Nooij, et al.
Blood|October 27, 1998
Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphomaM H Kramer, J Hermans, E Wijburg, et al.
Breast (Edinburgh, Scotland)|February 19, 2013
Prognostic value of geriatric assessment in older patients with advanced breast cancer receiving chemotherapyA A Aaldriks, E J Giltay, S le Cessie, et al.
Breast (Edinburgh, Scotland)|January 12, 2013
Slow accrual of elderly patients with metastatic breast cancer in the Dutch multicentre OMEGA studyM E Hamaker, C Seynaeve, J W R Nortier, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 17, 2011
High non-compliance in the use of letrozole after 2.5 years of extended adjuvant endocrine therapy. Results from the IDEAL randomized trialD B Y Fontein, J W R Nortier, G J Liefers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2009
Patterns of care in Dutch postmenopausal patients with hormone-sensitive early breast cancer participating in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trialJ G H van Nes, C Seynaeve, E Maartense, et al.
Critical Reviews in Oncology/Hematology|August 17, 2010
Predictive value of geriatric assessment for patients older than 70 years, treated with chemotherapyA A Aaldriks, E Maartense, S le Cessie, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2014
A randomized phase III study comparing pegylated liposomal doxorubicin with capecitabine as first-line chemotherapy in elderly patients with metastatic breast cancer: results of the OMEGA study of the Dutch Breast Cancer Research Group BOOGC H Smorenburg, S M de Groot, A E van Leeuwen-Stok, et al.
Breast Cancer Research and Treatment|September 16, 2015
CYP2D6 genotype- and endoxifen-guided tamoxifen dose escalation increases endoxifen serum concentrations without increasing side effectsV O Dezentjé, F L Opdam, H Gelderblom, et al.
Breast (Edinburgh, Scotland)|December 10, 2013
Baseline comprehensive geriatric assessment is associated with toxicity and survival in elderly metastatic breast cancer patients receiving single-agent chemotherapy: results from the OMEGA study of the Dutch breast cancer trialists' groupM E Hamaker, C Seynaeve, A N M Wymenga, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
British Journal of Cancer|June 13, 2001
Patients' preferences for adjuvant chemotherapy in early-stage breast cancer: is treatment worthwhile?S J Jansen, J Kievit, M A Nooij, et al.
Blood|October 27, 1998
Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphomaM H Kramer, J Hermans, E Wijburg, et al.
Breast (Edinburgh, Scotland)|February 19, 2013
Prognostic value of geriatric assessment in older patients with advanced breast cancer receiving chemotherapyA A Aaldriks, E J Giltay, S le Cessie, et al.
Breast (Edinburgh, Scotland)|January 12, 2013
Slow accrual of elderly patients with metastatic breast cancer in the Dutch multicentre OMEGA studyM E Hamaker, C Seynaeve, J W R Nortier, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 17, 2011
High non-compliance in the use of letrozole after 2.5 years of extended adjuvant endocrine therapy. Results from the IDEAL randomized trialD B Y Fontein, J W R Nortier, G J Liefers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2009
Patterns of care in Dutch postmenopausal patients with hormone-sensitive early breast cancer participating in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trialJ G H van Nes, C Seynaeve, E Maartense, et al.
Critical Reviews in Oncology/Hematology|August 17, 2010
Predictive value of geriatric assessment for patients older than 70 years, treated with chemotherapyA A Aaldriks, E Maartense, S le Cessie, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2014
A randomized phase III study comparing pegylated liposomal doxorubicin with capecitabine as first-line chemotherapy in elderly patients with metastatic breast cancer: results of the OMEGA study of the Dutch Breast Cancer Research Group BOOGC H Smorenburg, S M de Groot, A E van Leeuwen-Stok, et al.
Breast Cancer Research and Treatment|September 16, 2015
CYP2D6 genotype- and endoxifen-guided tamoxifen dose escalation increases endoxifen serum concentrations without increasing side effectsV O Dezentjé, F L Opdam, H Gelderblom, et al.
Breast (Edinburgh, Scotland)|December 10, 2013
Baseline comprehensive geriatric assessment is associated with toxicity and survival in elderly metastatic breast cancer patients receiving single-agent chemotherapy: results from the OMEGA study of the Dutch breast cancer trialists' groupM E Hamaker, C Seynaeve, A N M Wymenga, et al.
Pageof 4